FDA Approves First Cannabis-Derived Drug
On June 25, 2018, the FDA approved marijuana based Epidiolex, a drug targeting severe forms of epilepsy. Whereas other synthetic marijuana drugs are already on the market, Epidiolex marks the first cannabis plant derivative to receive FDA approval. Although marijuana remains a Schedule I substance...